DARE - Company ID 0001401914
The table below shows Dare Bioscience, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.03M | $9.78K | $2.81M | $10.00M | $0.00 | - |
| Cost of revenue | $295.80K | $0.00 | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $5.52M | $14.31M | $21.54M | $30.04M | $30.62M | $20.77M |
| SG&A |
Dare Bioscience, Inc. reported annual revenue of $1.03M for fiscal year 2025. That is up 10429.4% from $9.78K in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $625.00K (FY 2012) to $1.03M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $8.76M |
| $9.16M |
| $12.11M |
| $11.24M |
| $8.35M |
| $6.55M |
| Operating income | -$13.55M | -$23.45M | -$30.94M | -$31.39M | -$39.07M | -$27.40M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$13.40M | -$4.05M | -$30.16M | -$30.95M | -$38.70M | -$27.40M |
| EPS (diluted) | -$1.20 | -$0.48 | -$4.15 | -$0.37 | -$0.63 | -$0.91 |